Curaleaf Holdings (CURLF) Inventory Average (2020 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Inventory Average of $222.1 million for Q4 2024, up 1.91% year-on-year from $217.9 million in Q1 2024, and down 2.56% on a QoQ basis from $227.9 million in Q3 2024.

Curaleaf Holdings (CURLF) Inventory Average (2020 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Inventory Average for 5 consecutive years, with $222.1 million the latest figure, recorded in Q4 2024.

  • Quarterly Inventory Average rose 1.91% year-over-year to $222.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $222.1 million (up 1.91% YoY) and the FY2025 annual result came in at $221.0 million, up 2.1% from the prior year.
  • Inventory Average declined to $222.1 million in Q4 2024 per CURLF's latest filing, from $227.9 million in the prior quarter.
  • Over the last five years, Inventory Average for CURLF reached as high as $216.9 billion in Q2 2022 and fell as low as $190.4 million in Q4 2020.
  • A 5-year average of $33.6 billion and a median of $271.0 million in 2021 frame the typical range for Inventory Average.
  • Annual changes were most pronounced in 2022 — Inventory Average jumped 99536.33% — and 2023, when it plunged 46.38%.
  • Year by year, Inventory Average stood at $190.4 million in 2020, then surged by 56.05% to $297.2 million in 2021, then rose by 13.23% to $336.5 million in 2022, then tumbled by 35.25% to $217.9 million in 2023, then grew by 1.91% to $222.1 million in 2024.
  • According to Business Quant data, Inventory Average over the past three periods registered $222.1 million, $227.9 million, and $217.9 million for Q4 2024, Q3 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 1.45 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.18 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.51 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 9.02 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 180.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 2.11 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 3.96 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 66.75 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.73 Bn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 222.06 Mn
Sep 30, 2024 227.89 Mn
Dec 31, 2023 217.89 Mn
Sep 30, 2023 232.29 Mn
Dec 31, 2022 336.50 Mn
Sep 30, 2022 433.25 Mn
Jun 30, 2022 216.92 Bn
Mar 31, 2022 216.83 Bn
Dec 31, 2021 297.18 Mn
Sep 30, 2021 325.43 Mn
Jun 30, 2021 270.95 Mn
Mar 31, 2021 217.62 Mn
Dec 31, 2020 190.43 Mn